An Immersive PARP inhibitor Algorithm: Improving Clinical Outcomes Through PARP Inhibition in Patients with Advanced Ovarian Cancer

Target Audience

This activity is intended for medical oncologists, gynecologist oncologists, surgical oncologists, oncology nurses and other healthcare providers who care for patients with ovarian cancer, including physician assistants and nurse practitioners.

Program Overview

This digital algorithm offers stepwise practical guidance to prepare oncologists to employ PARP inhibitors effectively and safely in eligible ovarian cancer patients. Due to the many patient characteristics that determine eligibility, the algorithm supports branching logic in the context of patient disease status, response to chemotherapy, molecular profile, and tolerability.

Learning Objectives

Upon completion of this activity, participants will be able to:

Discuss strategies for identifying appropriate patients for implementation of PARP inhibitors in advanced ovarian cancer
Review clinical data on the safety, efficacy, and tolerability of PARP inhibitors in the maintenance and disease recurrence setting following platinum-based chemotherapy
Identify adverse events related to PARP inhibitors and outline potential strategies for management